Skip to main content
Livermore
Livermore
ZHEN

Orbis Allan Gray Ltd

SEC CIK
0001663865
Latest filing
Aug 14, 2026

ELV holding history

Elevance Health, Inc. in every 13F filed by Orbis Allan Gray Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ELV overviewAll 13F holders of ELVFull Q2 2026 holdings

Shares (Q2 2026)
183,191
Value
$70.8M
% of portfolio
0.2%
Quarters held
22
Since Q1 2021
Holdings of ELV by Orbis Allan Gray Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026183,191$70.8M0.2%00.0%UnchangedHolders
Q1 2026183,191$53.6M0.2%−1,061,755−85.3%ReducedHolders
Q4 20251,244,946$436.4M1.8%−63,172−4.8%ReducedHolders
Q3 20251,308,118$422.7M1.8%−1,547,732−54.2%ReducedHolders
Q2 20252,855,850$1.11B5.4%+6,677+0.2%AddedHolders
Q1 20252,849,173$1.24B7.1%+680,228+31.4%AddedHolders
Q4 20242,168,945$800.1M4.3%+1,264,048+139.7%AddedHolders
Q3 2024904,897$470.5M2.5%−19,892−2.2%ReducedHolders
Q2 2024924,789$501.1M3.1%−34,365−3.6%ReducedHolders
Q1 2024959,154$497.4M3.0%+57,548+6.4%AddedHolders
Q4 2023901,606$425.2M2.7%+15,775+1.8%AddedHolders
Q3 2023885,831$385.7M2.8%+136,418+18.2%AddedHolders
Q2 2023749,413$333.0M2.4%+60,883+8.8%AddedHolders
Q1 2023688,530$316.6M2.5%+100,389+17.1%AddedHolders
Q4 2022588,141$301.7M2.4%−112,530−16.1%ReducedHolders
Q3 2022700,671$318.3M2.6%−70,703−9.2%ReducedHolders
Q2 2022771,374$372.3M3.0%−541,565−41.2%ReducedHolders
Q1 20221,312,939$644.9M4.7%−223,392−14.5%ReducedHolders
Q4 20211,536,331$712.2M5.3%−181,718−10.6%ReducedHolders
Q3 20211,718,049$640.5M4.4%−427,561−19.9%ReducedHolders
Q2 20212,145,610$819.2M5.2%−321,677−13.0%ReducedHolders
Q1 20212,467,287$885.6M6.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.